Table 3 Mean Tariquidar total direct health-care costs (2010 Canadian dollars) in first year after index date in the hip fracture and non-hip fracture cohorts, by sex Resource type Females (N = 22,418) Males (N = 7,611) Hip fracture Non-hip fracture Attributable (95 % CI) % Hip fracture Non-hip fracture

Attributable (95 % CI) % Acute hospitalizations 21,502 2,710 18,792 (18,471, 19,119) 51 24,915 3,626 21,289 (20,573, 21,957) 54  Index hospitalization 14,210 – 14,210 (14,021, 14,400) 39 16,158 – 16,158 (15,711, 16,605) 41 Same day surgeries 120 153 −33 (−44, −22) 0 178 236 −58 (−83, −37) 0 Emergency visits 769 286 483 (472, 495) 1 831 322 509 (486, 532) 1 Complex continuing care 5,996 408 5,588 (5,323, 6,872) 15 6,934 466 6,468 (5,859, 7,037) 16 Rehabilitation 5,518 AZD6738 268 5,250 (5,107, 5,396) 14 5,700 247 5,453 (5,184, 5,730) 14 Long-term care 9,419 6,949 2,470 (2,315, 2,654) 7 6,746 5,494 1,252 (956, 1,521) 3 Home care 2,132 997 1,135 (1,069, 1,149) 3 2,050 705 1,345 (1,235, 1,458) 4 Physician services 4,525 1,422 3,103 (3,065, 3,142) 9 4,905 1,640 3,265 (3,190, 3,353) 8 Prescription medications 2,251 2,111 140 (102, 177) 0 2,030 2,073 −43 (−113, 34) 0 Total mean cost/year 52,232 15,303 36,929 (36,380, 37,466) 100 54,289 14,810 39,479 (38,331, 40,677)

100  Age group   66–69 45,886 7,020 38,866 (35,910, 41,608)   46,551 6,699 39,852 (35,439, 44,764)     70–74 47,250 9,373 37,877 (36,063, 39,850)   52,446 9,568 42,878 (39,501, 46,073)     75–79 50,924 12,437 38,487 (37,222, 38,489)   56,927 14,549 42,378 (39,472, 45,240)     80–84 52,863 14,859 38,004 (36,939, 39,111)   55,739 16,186 39,553 (37,312, 41,752)     85–89 54,542 17508 37,034 (36,023, 38,131)   54,456 16,647 37,809 (35,510, 40,251)     90+ 52,810 19,396 33,414 (32,119, 34,693)   52,405 18,433 33,972 (31,164, 36,869)   Attributable mean cost hip fracture cohort − mean cost non-hip fracture cohort, CI confidence interval Mean total and attributable hip fracture Hydroxychloroquine mw costs stratified by residence status, number

of hip fractures, and BMS202 solubility dmso survival status are summarized in Table 4. Among matched survivors, the mean 1-year attributable costs were $41,149 in females and $45,742 in males. First-year attributable costs among those who died in the first year were $10,935 among women and $14,451 among men. Among individuals who survived the first year, second-year attributable costs were $9,017 for women and $10,347 for men. LTC residence, acute hospitalizations, and home care accounted for the greatest proportion of the latter costs.